林奇综合征无症状患者监测性食管胃十二指肠镜的临床可干预发现
57例(17.6%)发现临床可干预病变,5例(1.5%)检出上消化道早期癌症,提示基线与随访EGD监测均能有效发现早期上消化道肿瘤。
要点
- 无症状林奇综合征患者监测性EGD中约1/6发现临床可干预病变。
- 5例(1.5%)检出上消化道癌症,均为早期阶段。
- 基线与随访EGD监测均能有效发现早期上消化道肿瘤。
核心结论
- 无症状林奇综合征患者监测性EGD中约1/6发现临床可干预病变,5例(1.5%)检出上消化道癌症且均为早期。
- 数据提示基线与随访EGD监测均能有效检测无症状林奇综合征患者的早期上消化道癌症。
研究设计与样本
- 回顾性分析人口学、基因型及EGD发现,评估临床可干预病变的频率,包括肿瘤(癌、腺瘤)、Barrett食管(BE)、幽门螺杆菌及>5 mm增生性息肉。
主要发现
- 57例(17.6%)检出临床可干预病变;基线EGD发现27.7%的病变,其余在平均3.5年的监测EGD中发现。
- 5例(1.5%)无症状患者在监测中检出上消化道癌症,均为早期,包括BE相关食管腺癌、胃神经内分泌肿瘤、胃腺癌各1例及十二指肠腺癌2例。
- 2例癌症在基线EGD发现,3例在随访EGD发现;每例患者平均2次EGD,检查间隔2.3年。
临床怎么用
- 对无症状林奇综合征患者可考虑基线与随访EGD监测,以发现早期上消化道癌症及临床可干预病变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Lynch syndrome (LS) predisposes patients to multiple cancers including of the gastric and small bowel. Data supporting EGD surveillance in LS are limited. Our aim is to describe upper GI (UGI) findings in asymptomatic LS patients undergoing EGD surveillance within a hereditary colorectal cancer registry. METHODS: Asymptomatic patients with LS who underwent ≥1 surveillance EGD were included. Demographics, genotype, and EGD findings were reviewed. The frequency of clinically actionable findings including neoplasia (cancer, adenomas), Barrett's esophagus (BE), Helicobacter pylori, and hyperplastic polyps >5 mm were assessed. RESULTS: Three hundred twenty-three patients underwent 717 EGDs starting at a median age of 49.5 years. On average, each patient had 2 EGDs with an interval of 2.3 years between examinations. Clinically actionable findings were identified in 57 patients (17.6%). On baseline EGD 27.7% of findings were identified, with the remainder on surveillance EGD over an average of 3.5 years. Five asymptomatic patients (1.5%) had an UGI cancer detected during surveillance, all at early stage, including 1 patient each with BE-related esophageal adenocarcinoma, gastric neuroendocrine tumor, and gastric adenocarcinoma and 2 patients with duodenal adenocarcinoma. Two cancers were found on baseline EGD and 3 on follow-up EGD. CONCLUSIONS: Clinically actionable findings were found in approximately 1 in 6 asymptomatic patients with LS undergoing EGD surveillance. Five patients (1.5%) were diagnosed with cancer, all detected at an early stage. These data suggest that both baseline and follow-up EGD surveillance are effective in detecting early-stage UGI cancers in asymptomatic patients with LS.
引用
- Farha N, Hrabe J, Sleiman J, et al. Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome. Gastrointest Endosc. 2021. PMID: 34252420. doi:10.1016/j.gie.2021.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。